You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

MACROBID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Macrobid patents expire, and what generic alternatives are available?

Macrobid is a drug marketed by Almatica and is included in one NDA.

The generic ingredient in MACROBID is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MACROBID?
  • What are the global sales for MACROBID?
  • What is Average Wholesale Price for MACROBID?
Summary for MACROBID
Drug patent expirations by year for MACROBID
Drug Prices for MACROBID

See drug prices for MACROBID

Drug Sales Revenue Trends for MACROBID

See drug sales revenues for MACROBID

Recent Clinical Trials for MACROBID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Albert Einstein Healthcare NetworkPhase 4
Baylor Research InstitutePhase 4
Roswell Park Cancer InstitutePhase 4

See all MACROBID clinical trials

Pharmacology for MACROBID

US Patents and Regulatory Information for MACROBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for MACROBID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 ⤷  Sign Up ⤷  Sign Up
Almatica MACROBID nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 020064-001 Dec 24, 1991 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for MACROBID

See the table below for patents covering MACROBID around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0250023 NITROFURANTOIN DOSAGE FORM ⤷  Sign Up
Germany 3772113 ⤷  Sign Up
Denmark 306487 ⤷  Sign Up
Austria A151687 ⤷  Sign Up
Philippines 22843 NITROFURANTOIN DOSAGE FORM ⤷  Sign Up
Austria A151587 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.